Toxikon Corporation

Allgemeine Informationen

Company Description

Toxikon is a preclinical Contract Research Organization (CRO). Located in a state-of-the art laboratory facility in Bedford, Massachusetts, and a second European lab operation in Leuven, Belgium. We contract and partner with biotech, pharmaceutical and medical device industries to deliver exceptional product development services from concept to final product.

Our professional and scientific staff is experienced in a comprehensive range of compound structures, therapeutic agents, and medical devices, including combinations products. We serve over 1,500 customers in more than 41 countries.

At Toxikon, We Pledge:

• To conduct the highest quality research and testing services in the industry;
• To assure you of a clean and comfortable environment when working on-site;
• To provide prompt, friendly, and courteous services by a knowledgeable and highly-trained staff;
• To be sensitive to special project needs and provide a detailed scope of services to be performed for every study/project;
• To deliver studies/projects to sponsor satisfaction, in a timely and efficient manner;
• To feature new services that represents the best current technology available;
• To respond in a rapid, sensitive, and constructive manner to requests that will enhance your outsourcing experience;
• To provide you with an experience that will encourage a continued partnership with Toxikon.

Company Background

For over thirty years, Toxikon’s scientists have collaborated with clients and their suppliers to ensure that drugs and devices are safe, effective and commercially available to meet therapeutic needs. We strive to remain at the forefront of life science technology development through innovative research, exceptional expertise, and services that are timely, efficient and cost-effective. Our Bedford, MA facilities offer full vivaria and fully equipped surgical suites, along with efficacy, research, histology, and clinical pathology services. Toxikon is registered with the FDA and the USDA and is AAALAC accredited. The company holds 34 permits and licenses.

Markets Served

Toxikon provides bioanalytical and preclinical research and testing services to the biotech, pharmaceutical, and medical device industries. Our therapeutic areas include, but are not limited to, cancer, neurodegenerative diseases, ocular (uveitis, glaucoma, dry eye, corneal, choroidial and retinal NV), IBD, dermatitis, obesity, and wound healing.

Products, Services & Capabilities

ISO 10993
In Vivo/In Vitro
501(K)
Analytical
Bioanalytical
PMA
Immunogencity
IDE
Toxicology
Ocular
R&D / Drug Discovery
IND/NDA Enabling Studies
Biocompatibility
Efficacy and Surgical Research
Extractables / Leachables
Risk Assessment